Is the function of the HBeAg really unknown?

References

• Huang H, Ning M, Liu J, Chen J, Feng J, Dai Y, Hu Y, Zhou YH. Comparison of antibody response to hepatitis B vaccination in infants with positive or negative maternal hepatitis B e antigen (HBeAg) in cord blood: implication for the role of HBeAg as an immunotolerogen, Human Vaccines & Immunotherapeutics. 2019, in press. doi:10.1080/21645515.2019.1575712.
   Google Scholar
• Zou H, Chen Y, Duan Z, Zhang H. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. PLoS One. 2011;6:e26748. doi:10.1371/journal.pone.0026748.
   PubMed Web of Science ®Google Scholar
• Stevens CE, Toy P, Kamili S, Taylor PE, Tong MJ, Xia G-L, Vyas GN. Eradicating hepatitis B virus: the critical role of preventing perinatal transmission. Biol J Int Assoc Biol Stand. 2017;50:3–19.
   Google Scholar
• Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990;87:6599–603. doi:10.1073/pnas.87.17.6599.
   PubMed Web of Science ®Google Scholar
• Milich DR, Chen MK, Hughes JL, Jones JE. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol. 1998;160:2013–21.
   PubMed Web of Science ®Google Scholar
• Chen MT, Billaud J-N, Sällberg M, Guidotti LG, Chisari FV, Jones J, Hughes J, Milich DR. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci U S A. 2004;101:14913–18. doi:10.1073/pnas.0406282101.
   PubMed Web of Science ®Google Scholar
• Shao Z-J, Zhang L, Xu J-Q, Xu D-Z, Men K, Zhang J-X, Cui H-C, Yan Y-P. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol. 2011;83:791–95. doi:10.1002/jmv.v83.5.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, Sun J, Hou J. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol. 2003;71:360–66. doi:10.1002/(ISSN)1096-9071.
   PubMed Web of Science ®Google Scholar
• Hsu HY, Chang MH, Hsieh KH, Lee CY, Lin HH, Hwang LH, Chen PJ, Chen DS. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology. 1992;15:770–76. doi:10.1002/hep.1840150505.
   PubMed Web of Science ®Google Scholar
• Magnius LO, Espmark JA. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol. 1972;109:1017–21.
   PubMed Web of Science ®Google Scholar
• Hadziyannis SJ, Papatheodoridis GV. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis. 2006;26:130–41. doi:10.1055/s-2006-939751.
   PubMed Web of Science ®Google Scholar
• Terazawa S, Kojima M, Yamanaka T, Yotsumoto S, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M. Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res. 1991;29:5–9. doi:10.1203/00006450-199101000-00002.
   PubMed Web of Science ®Google Scholar
• Chen H-L, Chang C-J, Kong M-S, Huang F-C, Lee H-C, Lin -C-C, Liu -C-C, Lee I-H, Wu T-C, Wu S-F, et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology. 2004;39:58–63. doi:10.1002/hep.20006.
   PubMed Web of Science ®Google Scholar
• Fagan EA, Smith PM, Davison F, Williams R. Fulminant hepatitis B in successive female sexual partners of two anti-HBe-positive males. Lancet. 1986;2:538–40.
   PubMed Web of Science ®Google Scholar
• Farci P, Diaz G, Chen Z, Govindarajan S, Tice A, Agulto L, Pittaluga S, Boon D, Yu C, Engle RE, et al. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci U S A. 2010;107:8766–71. doi:10.1073/pnas.0910097107.
   PubMed Web of Science ®Google Scholar
• Chen Z, Diaz G, Pollicino T, Zhao H, Engle RE, Schuck P, Shen C-H, Zamboni F, Long Z, Kabat J, et al. Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure. Proc Natl Acad Sci U S A. 2018;115:E11369–78. doi:10.1073/pnas.1809028115.
   PubMed Web of Science ®Google Scholar
• Kramvis A, Kostaki E-G, Hatzakis A, Paraskevis D. Immunomodulatory function of HBeAg related to short-sighted evolution, transmissibility, and clinical manifestation of hepatitis B virus. Front Microbiol. 2018;9:2521. doi:10.3389/fmicb.2018.02521.
   PubMed Web of Science ®Google Scholar
• Ozasa A, Tanaka Y, Orito E, Sugiyama M, Kang J-H, Hige S, Kuramitsu T, Suzuki K, Tanaka E, Okada S, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology. 2006;44:326–34. doi:10.1002/hep.21249.
   PubMed Web of Science ®Google Scholar
• Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol. 1990;145:3442–49.
   PubMed Web of Science ®Google Scholar
• Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, Chang TH, Chen DS. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest. 1992;89:87–96. doi:10.1172/JCI115590.
   PubMed Web of Science ®Google Scholar
• Park -J-J, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, et al. Hepatitis B virus–specific and global T-cell dysfunction in chronic hepatitis B. Gastroenterology. 2016;150:684–695 e5.
   PubMed Web of Science ®Google Scholar
• Martinet J, Leroy V, Dufeu-Duchesne T, Larrat S, Richard M-J, Zoulim F, Plumas J, Aspord C. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. Hepatology. 2012;56:1706–18. doi:10.1002/hep.25938.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Mitsui H, Maekawa H, Yamada H, Hirayama M, Iino S, Yasuda K, Koike K, Kimura S, Milich DR. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region. Am J Gastroenterol. 2000;95:2894–904. doi:10.1111/j.1572-0241.2000.03381.x.
   PubMed Web of Science ®Google Scholar
• Visvanathan K, Skinner NA, Thompson AJV, Riordan SM, Sozzi V, Edwards R, Rodgers S, Kurtovic J, Chang J, Lewin S, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 2007;45:102–10. doi:10.1002/hep.21482.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cui L, Yang G, Zhan J, Guo L, Chen Y, Fan C, Liu D, Guo D. Hepatitis B e antigen inhibits NF-κB activity by interrupting K63-linked ubiquitination of NEMO. J Virol. 2018. doi:10.1128/JVI.00667-18.
   Web of Science ®Google Scholar
• Jegaskanda S, Ahn SH, Skinner N, Thompson AJ, Ngyuen T, Holmes J, De Rose R, Navis M, Winnall WR, Kramski M, et al. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen. J Virol. 2014;88:10412–20. doi:10.1128/JVI.00111-14.
   PubMed Web of Science ®Google Scholar
• Wu S, Kanda T, Imazeki F, Nakamoto S, Tanaka T, Arai M, Roger T, Shirasawa H, Nomura F, Yokosuka O. Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression. J Infect Dis. 2012;206:415–20. doi:10.1093/infdis/jis363.
   PubMed Web of Science ®Google Scholar
• Yang C-Y, Kuo T-H, Ting L-P. Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. J Biol Chem. 2006;281:34525–36. doi:10.1074/jbc.M510981200.
   PubMed Web of Science ®Google Scholar
• Chang C, Enders G, Sprengel R, Peters N, Varmus HE, Ganem D. Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J Virol. 1987;61:3322–25.
   PubMed Web of Science ®Google Scholar
• Schlicht HJ, Salfeld J, Schaller H. The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J Virol. 1987;61:3701–09.
   PubMed Web of Science ®Google Scholar
• Chen HS, Kew MC, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J Virol. 1992;66:5682–84.
   PubMed Web of Science ®Google Scholar
• Revill P, Yuen L, Walsh R, Perrault M, Locarnini S, Kramvis A. Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses. J Med Virol. 2010;82:104–15. doi:10.1002/jmv.v82:1.
   PubMed Web of Science ®Google Scholar
• Frelin L, Wahlström T, Tucker AE, Jones J, Hughes J, Lee BO, Billaud J-N, Peters C, Whitacre D, Peterson D, et al. A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection. J Virol. 2009;83:1379–92. doi:10.1128/JVI.02516-08.
   PubMedGoogle Scholar
• Chen M, Sällberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, Billaud J-N, Milich DR. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol. 2005;79:3016–27. doi:10.1128/JVI.79.20.12905-12913.2005.
   PubMed Web of Science ®Google Scholar
• Tian Y, Kuo C-F, Akbari O, Ou J-HJ. Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission. Immunity. 2016;44:1204–14. doi:10.1016/j.immuni.2016.04.008.
   PubMed Web of Science ®Google Scholar
• Chen M, Sällberg M, Thung SN, Hughes J, Jones J, Milich DR. Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection. J Virol. 2000;74:7587–99. doi:10.1128/JVI.74.16.7587-7599.2000.
   PubMed Web of Science ®Google Scholar
• Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, et al. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest. 2013;123:3728–39. doi:10.1172/JCI68182.
   PubMed Web of Science ®Google Scholar
• Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology. 2003;38:1075–86. doi:10.1053/jhep.2003.50453.
   PubMed Web of Science ®Google Scholar